K-Frage der Union: Laschet boxt sich durch

Der CDU-Chef und NRW-Ministerpräsident hat den Parteivorstand mehrheitlich auf seine Seite gebracht, geht aber keinesfalls unbeschädigt in den Wahlkampf. Ob CSU-Chef Söder nun wirklich aufgibt, steht noch nicht fest

Der CDU-Chef und NRW-Ministerpräsident hat den Parteivorstand mehrheitlich auf seine Seite gebracht, geht aber keinesfalls unbeschädigt in den Wahlkampf. Ob CSU-Chef Söder nun wirklich aufgibt, steht noch nicht fest

Produkthype: Warum nimmt Apple den Store immer offline?

Aus technischer Sicht gibt es keinen Grund dafür, den Apple-Store vor jeder Keynote offline zu stellen. Dem Hype ist es aber zuträglich. Von Mike Wobker (Apple, Wirtschaft)

Aus technischer Sicht gibt es keinen Grund dafür, den Apple-Store vor jeder Keynote offline zu stellen. Dem Hype ist es aber zuträglich. Von Mike Wobker (Apple, Wirtschaft)

Auto Shanghai 2021: Huawei zeigt Elektroauto

Das Cyrus Huawei Smart Selection SF5 ist ein Elektro-SUV, das nicht nur mit dem Huawei-Logo, sondern auch mit viel Technik vollgestopft ist. (Huawei, Technologie)

Das Cyrus Huawei Smart Selection SF5 ist ein Elektro-SUV, das nicht nur mit dem Huawei-Logo, sondern auch mit viel Technik vollgestopft ist. (Huawei, Technologie)

IT-Konsolidierung des Bundes: Bundesclient verzögert sich offenbar bis 2032

Der Bundesrechnungshof warnt vor Verzögerungen bei den standardisierten IT-Arbeitsplätzen beim Bund. Diese könnten schon vor der Einführung veraltet sein. (IT-Konsolidierung, Server)

Der Bundesrechnungshof warnt vor Verzögerungen bei den standardisierten IT-Arbeitsplätzen beim Bund. Diese könnten schon vor der Einführung veraltet sein. (IT-Konsolidierung, Server)

Marvel drops first teaser for Shang-Chi and the Legend of Ten Rings

Simu Liu stars as a gifted martial artist seeking to escape his dark family history.

Simu Liu stars as a martial artist trying to escape his past in Shang-Chi and the Legend of the Ten Rings.

A young man who once trained as an assassin for a Chinese criminal organization discovers just how hard it can be to escape one's past in the first teaser for Marvel Studios' upcoming film, Shang-Chi and the Legend of Ten Rings, part of the MCU's Phase Four. Directed by Destin Daniel Cretton, it is the first Marvel film to feature an Asian lead—Simu Liu, best known for his role as Jung Kim on the sitcom Kim's Convenience—as well as a predominantly Asian/Asian diaspora cast and crew.

The title character first appeared in a Marvel comic in 1973, after the company had tried and failed to acquire the comic book rights for the popular 1970s TV show Kung Fu (starring David Carradine). Modeled in part on Bruce Lee, Shang-Chi was originally the son of Chinese criminal mastermind Dr. Fu Manchu, trained in martial arts since childhood to become an assassin. After Marvel lost the rights to the Fu Manchu character, Shang-Chi's paternity became murkier, but the international crime lord theme was common—although his father was revealed to be an ancient immortal sorcerer in the Secret Avengers storyline.

Shang-Chi has not traditionally had special superpowers, but his training in multiple styles of martial arts and assorted weaponry makes him a formidable opponent and a useful ally. Plus, he is a master of chi, making him even stronger and faster—fast enough to dodge bullets. When he eventually joins forces with the Avengers in the comics, Tony Stark gives him a pair of bracelets to further focus his chi (as well as some snazzy high-tech nunchaku).

Read 5 remaining paragraphs | Comments

More J&J troubles: Vaccine manufacturing halted and more possible clot cases

CDC advisory committee will meet Friday to decide the fate of the troubled vaccine.

The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021.

Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. (credit: Getty | Saul Loeb)

The US Food and Drug Administration last week asked Emergent BioSolutions to stop making Johnson & Johnson’s COVID-19 vaccine at its troubled facility in Baltimore, according to a regulatory filing Emergent released Monday.

The FDA had begun an inspection of the contract manufacturer’s facility on April 12 but requested on April 16 that production be halted “pending completion of the inspection and remediation of any resulting findings,” the filing reads. Any vaccine materials already made at the plant will be held in quarantine.

The production halt follows news last month that a mishap at the plant led to the ruin of 15 million doses of Johnson & Johnson’s one-shot COVID-19 vaccine. The ruined doses had reportedly been contaminated with ingredients from AstraZeneca’s COVID-19 vaccine, which was also being manufactured at the plant at the time.

Read 10 remaining paragraphs | Comments